Copy Link Print Information

Plutavimab

(Synonyms: COVI-AMG; STI-2020)
Customer Review

Based on 1 Customer Validation

Plutavimab a human IgG1-κ anti-SARS-CoV-2 antibody, targeting to Spike (S) glycoprotein receptor binding domain (RBD).

For research use only. We do not sell to patients.

  • Purity: 98.619%
  • CAS No.: 2529854-88-2
  • Molecular Weight:143.981 kDa
  • Storage:

    Please store the product under the recommended conditions in the Certificate of Analysis.

  • Experimental Validation Results for Plutavimab
  • Experimental Validation Results for Plutavimab
  • Plutavimab Chemical Structure
    Plutavimab Chemical Structure
CAS No.: 2529854-88-2
Size
Price
Stock
Quantity
Amount: USD 0.00
Please select quantity
or
or

* Please select Quantity before adding items.

To place orders, for customer services and technical support, please contact: MedChemExpress USA

Tel: 609-228-6898 E-mail: [email protected] [email protected]

Data Download
Plutavimab Product Recommendations:

To place orders, for customer services and technical support, please contact:

609-228-6898
[email protected] [email protected]
Find Your Local Distributor Your local distributor: Hycultec GmbHHycultec
  • Biological Activity
  • Chemical Information
  • Purity & Documentation
  • References
  • Help & FAQs
You May Still Need
Top Publications Citing

Use of MCE Products
Keywords
100 mg

Get Quote In-stock

Please select quantity
Amount: USD 0.00
Sign in to MedChemExpress Sign In
Register
Sign in to MedChemExpress
Register New Account

At least 6 characters

Personalize your experience, you are currently not signed in. For a better experience, please create an online profile, you can:

Obtain points redemption prizes
Check out faster
Add multiple shipping locations
View orders
Assay Types
  • 1/16

    Human IgG1 kappa

  • 1/16

    Immobilized SARS-CoV-2 S Protein RBD (HEK293, Fc, HY-P73397) can bind Plutavimab. The EC50 for this effect is 12.88 ng/mL.

  • Plutavimab Chemical Structure
    1/16
  • Plutavimab
  • Immobilized SARS-CoV-2 S Protein RBD (HEK293, Fc, HY-P73397) can bind Plutavimab. The EC50 for this effect is 12.88 ng/mL.